1,878
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Recurrence of Major Depressive Disorder Following a Switch from Escitalopram to St. John's Wort: A Case Report

Majör depresif bozuklukta essitalopram'dan sarı kantaron'a geçilmesini izleyen yineleme: Bir olgu sunumu

, M.D.
Pages 180-183 | Received 18 Jun 2013, Accepted 30 Jul 2013, Published online: 08 Nov 2016
 

ABSTRACT

Hypericum perforatum extracts, popularly known as St. John's wort (known as “sarı kantaron” in Turkish) are widely used for the treatment of major depression, especially in German speaking countries. Data on the effectiveness of such extracts for the maintenance treatment of major depression is limited. In this case report, a female patient who was euthymic under escitalopram treatment and experienced a recurrence of depression following a switch to St. John's wort will be described.

ÖZET

Ülkemizde daha çok sarı kantaron, yurt dışında ise St. John's wort olarak bilinen hypericum perforatum bitkisinden elde edilen ekstreler, özellikle Almanca konuşulan ülkelerde majör depresyon tedavisinde yaygın olarak kullanılmaktadır. Bu maddelerin majör depresyonun idame tedavisindeki etkinliği hakkındaki veriler sınırlıdır. Bu olgu sunumunda yineleyici majör depresif bozukluğu olup, ötimik dönemde iken idame tedavisi olarak kullandığı essitalopramın yerine sarı kantaron kullanmaya başlamasının ardından depresyonu yineleyen bir kadın hasta bildirilmektedir.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.